Loading…

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2 . Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes....

Full description

Saved in:
Bibliographic Details
Published in:Molecular neurobiology 2021-05, Vol.58 (5), p.2158-2182
Main Authors: Morris, G., Walker, A. J., Walder, K., Berk, M., Marx, W., Carvalho, A. F., Maes, M., Puri, B. K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63
cites cdi_FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63
container_end_page 2182
container_issue 5
container_start_page 2158
container_title Molecular neurobiology
container_volume 58
creator Morris, G.
Walker, A. J.
Walder, K.
Berk, M.
Marx, W.
Carvalho, A. F.
Maes, M.
Puri, B. K.
description Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2 . Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes. Nrf2 upregulation is associated with increased cellular levels of glutathione disulfide, glutathione peroxidase, glutathione transferases, thioredoxin and thioredoxin reductase. Given its key role in governing the cellular antioxidant response, upregulation of Nrf2 has been suggested as a common therapeutic target in neuropsychiatric illnesses such as major depressive disorder, bipolar disorder and schizophrenia, which are associated with chronic oxidative and nitrosative stress, characterised by elevated levels of reactive oxygen species, nitric oxide and peroxynitrite. These processes lead to extensive lipid peroxidation, protein oxidation and carbonylation, and oxidative damage to nuclear and mitochondrial DNA. Intake of N -acetylcysteine, coenzyme Q 10 and melatonin is accompanied by increased Nrf2 activity. N -acetylcysteine intake is associated with improved cerebral mitochondrial function, decreased central oxidative and nitrosative stress, reduced neuroinflammation, alleviation of endoplasmic reticular stress and suppression of the unfolded protein response. Coenzyme Q 10 , which acts as a superoxide scavenger in neuroglial mitochondria, instigates mitohormesis, ameliorates lipid peroxidation in the inner mitochondrial membrane, activates uncoupling proteins, promotes mitochondrial biogenesis and has positive effects on the plasma membrane redox system. Melatonin, which scavenges mitochondrial free radicals, inhibits mitochondrial nitric oxide synthase, restores mitochondrial calcium homeostasis, deacetylates and activates mitochondrial SIRT3, ameliorates increased permeability of the blood-brain barrier and intestine and counters neuroinflammation and glutamate excitotoxicity.
doi_str_mv 10.1007/s12035-020-02212-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2476126632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2508022686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxhQJBaWgH12bGesKj4qVWXpbjmu06ZqkmInoPx7HFJAYmA43XDPvXd6ELom-J5gLB48AUyTGAMOBQTijxM0JkmSxoRIOEVjLFMaC87kCF14v8M9hcU5GlHKCAEmx2g2r4yz2hfVJlq6HKKpaYr3ouki7SMdrcKsKW3VRNPDwdXabKOiipa2dfXBd2Zb6MZ1l-gs13tvr459glZPj6vZS7x4fZ7PpovYMEaaOJyk1CQ6g4zRTBhLUwuWS8gTALrmaWLACCOlxVIIkguZ9gjDVubScjpBd0NseOSttb5RZeGN3e91ZevWK2CCE-CcQkBv_6C7unVVeE5BgmXwwGUfCANlXO29s7k6uKLUrlMEq96wGgyrYFh9GVYfYenmGN1mpV3_rHwrDQAdAB9G1ca639v_xH4Cv9KE5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2508022686</pqid></control><display><type>article</type><title>Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry</title><source>Springer Link</source><creator>Morris, G. ; Walker, A. J. ; Walder, K. ; Berk, M. ; Marx, W. ; Carvalho, A. F. ; Maes, M. ; Puri, B. K.</creator><creatorcontrib>Morris, G. ; Walker, A. J. ; Walder, K. ; Berk, M. ; Marx, W. ; Carvalho, A. F. ; Maes, M. ; Puri, B. K.</creatorcontrib><description>Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2 . Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes. Nrf2 upregulation is associated with increased cellular levels of glutathione disulfide, glutathione peroxidase, glutathione transferases, thioredoxin and thioredoxin reductase. Given its key role in governing the cellular antioxidant response, upregulation of Nrf2 has been suggested as a common therapeutic target in neuropsychiatric illnesses such as major depressive disorder, bipolar disorder and schizophrenia, which are associated with chronic oxidative and nitrosative stress, characterised by elevated levels of reactive oxygen species, nitric oxide and peroxynitrite. These processes lead to extensive lipid peroxidation, protein oxidation and carbonylation, and oxidative damage to nuclear and mitochondrial DNA. Intake of N -acetylcysteine, coenzyme Q 10 and melatonin is accompanied by increased Nrf2 activity. N -acetylcysteine intake is associated with improved cerebral mitochondrial function, decreased central oxidative and nitrosative stress, reduced neuroinflammation, alleviation of endoplasmic reticular stress and suppression of the unfolded protein response. Coenzyme Q 10 , which acts as a superoxide scavenger in neuroglial mitochondria, instigates mitohormesis, ameliorates lipid peroxidation in the inner mitochondrial membrane, activates uncoupling proteins, promotes mitochondrial biogenesis and has positive effects on the plasma membrane redox system. Melatonin, which scavenges mitochondrial free radicals, inhibits mitochondrial nitric oxide synthase, restores mitochondrial calcium homeostasis, deacetylates and activates mitochondrial SIRT3, ameliorates increased permeability of the blood-brain barrier and intestine and counters neuroinflammation and glutamate excitotoxicity.</description><identifier>ISSN: 0893-7648</identifier><identifier>EISSN: 1559-1182</identifier><identifier>DOI: 10.1007/s12035-020-02212-w</identifier><identifier>PMID: 33411248</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acetylcysteine ; Antioxidants ; Biomedical and Life Sciences ; Biomedicine ; Bipolar disorder ; Blood-brain barrier ; Calcium (mitochondrial) ; Calcium homeostasis ; Calcium oxide ; Calcium permeability ; Cell Biology ; Coenzyme Q10 ; Excitotoxicity ; Free radicals ; Glutathione peroxidase ; Homeostasis ; Inflammation ; Intestine ; Lipid peroxidation ; Melatonin ; Membrane permeability ; Mental disorders ; Mitochondrial DNA ; Neurobiology ; Neurology ; Neurosciences ; Nitric oxide ; Nitric-oxide synthase ; Oxidative stress ; Peroxynitrite ; Reactive oxygen species ; Reviews ; Schizophrenia ; Therapeutic targets</subject><ispartof>Molecular neurobiology, 2021-05, Vol.58 (5), p.2158-2182</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63</citedby><cites>FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63</cites><orcidid>0000-0001-6101-0139</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33411248$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morris, G.</creatorcontrib><creatorcontrib>Walker, A. J.</creatorcontrib><creatorcontrib>Walder, K.</creatorcontrib><creatorcontrib>Berk, M.</creatorcontrib><creatorcontrib>Marx, W.</creatorcontrib><creatorcontrib>Carvalho, A. F.</creatorcontrib><creatorcontrib>Maes, M.</creatorcontrib><creatorcontrib>Puri, B. K.</creatorcontrib><title>Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry</title><title>Molecular neurobiology</title><addtitle>Mol Neurobiol</addtitle><addtitle>Mol Neurobiol</addtitle><description>Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2 . Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes. Nrf2 upregulation is associated with increased cellular levels of glutathione disulfide, glutathione peroxidase, glutathione transferases, thioredoxin and thioredoxin reductase. Given its key role in governing the cellular antioxidant response, upregulation of Nrf2 has been suggested as a common therapeutic target in neuropsychiatric illnesses such as major depressive disorder, bipolar disorder and schizophrenia, which are associated with chronic oxidative and nitrosative stress, characterised by elevated levels of reactive oxygen species, nitric oxide and peroxynitrite. These processes lead to extensive lipid peroxidation, protein oxidation and carbonylation, and oxidative damage to nuclear and mitochondrial DNA. Intake of N -acetylcysteine, coenzyme Q 10 and melatonin is accompanied by increased Nrf2 activity. N -acetylcysteine intake is associated with improved cerebral mitochondrial function, decreased central oxidative and nitrosative stress, reduced neuroinflammation, alleviation of endoplasmic reticular stress and suppression of the unfolded protein response. Coenzyme Q 10 , which acts as a superoxide scavenger in neuroglial mitochondria, instigates mitohormesis, ameliorates lipid peroxidation in the inner mitochondrial membrane, activates uncoupling proteins, promotes mitochondrial biogenesis and has positive effects on the plasma membrane redox system. Melatonin, which scavenges mitochondrial free radicals, inhibits mitochondrial nitric oxide synthase, restores mitochondrial calcium homeostasis, deacetylates and activates mitochondrial SIRT3, ameliorates increased permeability of the blood-brain barrier and intestine and counters neuroinflammation and glutamate excitotoxicity.</description><subject>Acetylcysteine</subject><subject>Antioxidants</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bipolar disorder</subject><subject>Blood-brain barrier</subject><subject>Calcium (mitochondrial)</subject><subject>Calcium homeostasis</subject><subject>Calcium oxide</subject><subject>Calcium permeability</subject><subject>Cell Biology</subject><subject>Coenzyme Q10</subject><subject>Excitotoxicity</subject><subject>Free radicals</subject><subject>Glutathione peroxidase</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Intestine</subject><subject>Lipid peroxidation</subject><subject>Melatonin</subject><subject>Membrane permeability</subject><subject>Mental disorders</subject><subject>Mitochondrial DNA</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Nitric oxide</subject><subject>Nitric-oxide synthase</subject><subject>Oxidative stress</subject><subject>Peroxynitrite</subject><subject>Reactive oxygen species</subject><subject>Reviews</subject><subject>Schizophrenia</subject><subject>Therapeutic targets</subject><issn>0893-7648</issn><issn>1559-1182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwBxhQJBaWgH12bGesKj4qVWXpbjmu06ZqkmInoPx7HFJAYmA43XDPvXd6ELom-J5gLB48AUyTGAMOBQTijxM0JkmSxoRIOEVjLFMaC87kCF14v8M9hcU5GlHKCAEmx2g2r4yz2hfVJlq6HKKpaYr3ouki7SMdrcKsKW3VRNPDwdXabKOiipa2dfXBd2Zb6MZ1l-gs13tvr459glZPj6vZS7x4fZ7PpovYMEaaOJyk1CQ6g4zRTBhLUwuWS8gTALrmaWLACCOlxVIIkguZ9gjDVubScjpBd0NseOSttb5RZeGN3e91ZevWK2CCE-CcQkBv_6C7unVVeE5BgmXwwGUfCANlXO29s7k6uKLUrlMEq96wGgyrYFh9GVYfYenmGN1mpV3_rHwrDQAdAB9G1ca639v_xH4Cv9KE5A</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Morris, G.</creator><creator>Walker, A. J.</creator><creator>Walder, K.</creator><creator>Berk, M.</creator><creator>Marx, W.</creator><creator>Carvalho, A. F.</creator><creator>Maes, M.</creator><creator>Puri, B. K.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QR</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6101-0139</orcidid></search><sort><creationdate>20210501</creationdate><title>Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry</title><author>Morris, G. ; Walker, A. J. ; Walder, K. ; Berk, M. ; Marx, W. ; Carvalho, A. F. ; Maes, M. ; Puri, B. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetylcysteine</topic><topic>Antioxidants</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bipolar disorder</topic><topic>Blood-brain barrier</topic><topic>Calcium (mitochondrial)</topic><topic>Calcium homeostasis</topic><topic>Calcium oxide</topic><topic>Calcium permeability</topic><topic>Cell Biology</topic><topic>Coenzyme Q10</topic><topic>Excitotoxicity</topic><topic>Free radicals</topic><topic>Glutathione peroxidase</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Intestine</topic><topic>Lipid peroxidation</topic><topic>Melatonin</topic><topic>Membrane permeability</topic><topic>Mental disorders</topic><topic>Mitochondrial DNA</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Nitric oxide</topic><topic>Nitric-oxide synthase</topic><topic>Oxidative stress</topic><topic>Peroxynitrite</topic><topic>Reactive oxygen species</topic><topic>Reviews</topic><topic>Schizophrenia</topic><topic>Therapeutic targets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morris, G.</creatorcontrib><creatorcontrib>Walker, A. J.</creatorcontrib><creatorcontrib>Walder, K.</creatorcontrib><creatorcontrib>Berk, M.</creatorcontrib><creatorcontrib>Marx, W.</creatorcontrib><creatorcontrib>Carvalho, A. F.</creatorcontrib><creatorcontrib>Maes, M.</creatorcontrib><creatorcontrib>Puri, B. K.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morris, G.</au><au>Walker, A. J.</au><au>Walder, K.</au><au>Berk, M.</au><au>Marx, W.</au><au>Carvalho, A. F.</au><au>Maes, M.</au><au>Puri, B. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry</atitle><jtitle>Molecular neurobiology</jtitle><stitle>Mol Neurobiol</stitle><addtitle>Mol Neurobiol</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>58</volume><issue>5</issue><spage>2158</spage><epage>2182</epage><pages>2158-2182</pages><issn>0893-7648</issn><eissn>1559-1182</eissn><abstract>Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2 . Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes. Nrf2 upregulation is associated with increased cellular levels of glutathione disulfide, glutathione peroxidase, glutathione transferases, thioredoxin and thioredoxin reductase. Given its key role in governing the cellular antioxidant response, upregulation of Nrf2 has been suggested as a common therapeutic target in neuropsychiatric illnesses such as major depressive disorder, bipolar disorder and schizophrenia, which are associated with chronic oxidative and nitrosative stress, characterised by elevated levels of reactive oxygen species, nitric oxide and peroxynitrite. These processes lead to extensive lipid peroxidation, protein oxidation and carbonylation, and oxidative damage to nuclear and mitochondrial DNA. Intake of N -acetylcysteine, coenzyme Q 10 and melatonin is accompanied by increased Nrf2 activity. N -acetylcysteine intake is associated with improved cerebral mitochondrial function, decreased central oxidative and nitrosative stress, reduced neuroinflammation, alleviation of endoplasmic reticular stress and suppression of the unfolded protein response. Coenzyme Q 10 , which acts as a superoxide scavenger in neuroglial mitochondria, instigates mitohormesis, ameliorates lipid peroxidation in the inner mitochondrial membrane, activates uncoupling proteins, promotes mitochondrial biogenesis and has positive effects on the plasma membrane redox system. Melatonin, which scavenges mitochondrial free radicals, inhibits mitochondrial nitric oxide synthase, restores mitochondrial calcium homeostasis, deacetylates and activates mitochondrial SIRT3, ameliorates increased permeability of the blood-brain barrier and intestine and counters neuroinflammation and glutamate excitotoxicity.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33411248</pmid><doi>10.1007/s12035-020-02212-w</doi><tpages>25</tpages><orcidid>https://orcid.org/0000-0001-6101-0139</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0893-7648
ispartof Molecular neurobiology, 2021-05, Vol.58 (5), p.2158-2182
issn 0893-7648
1559-1182
language eng
recordid cdi_proquest_miscellaneous_2476126632
source Springer Link
subjects Acetylcysteine
Antioxidants
Biomedical and Life Sciences
Biomedicine
Bipolar disorder
Blood-brain barrier
Calcium (mitochondrial)
Calcium homeostasis
Calcium oxide
Calcium permeability
Cell Biology
Coenzyme Q10
Excitotoxicity
Free radicals
Glutathione peroxidase
Homeostasis
Inflammation
Intestine
Lipid peroxidation
Melatonin
Membrane permeability
Mental disorders
Mitochondrial DNA
Neurobiology
Neurology
Neurosciences
Nitric oxide
Nitric-oxide synthase
Oxidative stress
Peroxynitrite
Reactive oxygen species
Reviews
Schizophrenia
Therapeutic targets
title Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A00%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increasing%20Nrf2%20Activity%20as%20a%20Treatment%20Approach%20in%20Neuropsychiatry&rft.jtitle=Molecular%20neurobiology&rft.au=Morris,%20G.&rft.date=2021-05-01&rft.volume=58&rft.issue=5&rft.spage=2158&rft.epage=2182&rft.pages=2158-2182&rft.issn=0893-7648&rft.eissn=1559-1182&rft_id=info:doi/10.1007/s12035-020-02212-w&rft_dat=%3Cproquest_cross%3E2508022686%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-41133c5ab2b43b7ce39e2e682f5223d695c2c7c88e08771f789e39e40e8f8e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2508022686&rft_id=info:pmid/33411248&rfr_iscdi=true